Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Collegium Pharmaceutical (COLL) EBT: 2014-2024

Historic EBT for Collegium Pharmaceutical (COLL) over the last 11 years, with Dec 2024 value amounting to $98.6 million.

  • Collegium Pharmaceutical's EBT rose 178.79% to $43.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.9 million, marking a year-over-year decrease of 36.84%. This contributed to the annual value of $98.6 million for FY2024, which is 30.15% up from last year.
  • Latest data reveals that Collegium Pharmaceutical reported EBT of $98.6 million as of FY2024, which was up 30.15% from $75.7 million recorded in FY2023.
  • Over the past 5 years, Collegium Pharmaceutical's EBT peaked at $98.6 million during FY2024, and registered a low of -$28.8 million during FY2022.
  • In the last 3 years, Collegium Pharmaceutical's EBT had a median value of $75.7 million in 2023 and averaged $48.5 million.
  • In the last 5 years, Collegium Pharmaceutical's EBT crashed by 754.98% in 2022 and then soared by 362.53% in 2023.
  • Collegium Pharmaceutical's EBT (Yearly) stood at $27.6 million in 2020, then tumbled by 112.23% to -$3.4 million in 2021, then slumped by 754.98% to -$28.8 million in 2022, then skyrocketed by 362.53% to $75.7 million in 2023, then spiked by 30.15% to $98.6 million in 2024.